A previous report indicated that JNK inhibition may aid in the treatment of neurodegenerative diseases 27 by reducing neuronal apoptosis and that activation of the cAMP-PKA/CREB1 signaling pathway can suppress JNK activation and antagonize apoptosis 28, 29. The gene discussed is CREB1; the disease is neurodegenerative disease.